| Cancer stemness meets immunity: from mechanism to therapy P Chen, WH Hsu, J Han, Y Xia, RA DePinho Cell reports 34 (1), 2021 | 139 | 2021 |
| Snail-induced claudin-11 prompts collective migration for tumour progression CF Li, JY Chen, YH Ho, WH Hsu, LC Wu, HY Lan, DSS Hsu, SK Tai, ... Nature cell biology 21 (2), 251-262, 2019 | 127 | 2019 |
| Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment P Chen, WH Hsu, A Chang, Z Tan, Z Lan, A Zhou, DJ Spring, FF Lang, ... Cancer discovery 10 (3), 371-381, 2020 | 115 | 2020 |
| Connective tissue growth factor activates pluripotency genes and mesenchymal–epithelial transition in head and neck cancer cells CC Chang, WH Hsu, CC Wang, CH Chou, MYP Kuo, BR Lin, ST Chen, ... Cancer research 73 (13), 4147-4157, 2013 | 100 | 2013 |
| ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer RCE Hsieh, S Krishnan, RC Wu, AR Boda, A Liu, M Winkler, WH Hsu, ... Science immunology 7 (72), eabl9330, 2022 | 61 | 2022 |
| Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation WH Yang, YH Su, WH Hsu, CC Wang, JL Arbiser, MH Yang Oncogene 35 (18), 2287-2298, 2016 | 51 | 2016 |
| let-7 modulates chromatin configuration and target gene repression through regulation of the ARID3B complex TT Liao, WH Hsu, CH Ho, WL Hwang, HY Lan, T Lo, CC Chang, SK Tai, ... Cell reports 14 (3), 520-533, 2016 | 49 | 2016 |
| Circadian regulator CLOCK drives immunosuppression in glioblastoma W Xuan, WH Hsu, F Khan, M Dunterman, L Pang, DA Wainwright, ... Cancer immunology research 10 (6), 770-784, 2022 | 38 | 2022 |
| Telomere dysfunction instigates inflammation in inflammatory bowel disease D Chakravarti, R Lee, AS Multani, A Santoni, Z Keith, WH Hsu, K Chang, ... Proceedings of the National Academy of Sciences 118 (29), e2024853118, 2021 | 31 | 2021 |
| Lymphotoxin-β interacts with methylated EGFR to mediate acquired resistance to cetuximab in head and neck cancer DSS Hsu, WL Hwang, CH Yuh, CH Chu, YH Ho, PB Chen, HS Lin, HK Lin, ... Clinical Cancer Research 23 (15), 4388-4401, 2017 | 30 | 2017 |
| Telomerase reverse transcriptase preserves neuron survival and cognition in Alzheimer’s disease models HS Shim, JW Horner, CJ Wu, J Li, ZD Lan, S Jiang, X Xu, WH Hsu, T Zal, ... Nature aging 1 (12), 1162-1174, 2021 | 26 | 2021 |
| Histone demethylase KDM5D upregulation drives sex differences in colon cancer J Li, Z Lan, W Liao, JW Horner, X Xu, J Liu, Y Yoshihama, S Jiang, ... Nature 619 (7970), 632-639, 2023 | 23 | 2023 |
| Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer R Lee, J Li, J Li, CJ Wu, S Jiang, WH Hsu, D Chakravarti, P Chen, ... Cancer discovery 12 (7), 1702-1717, 2022 | 19 | 2022 |
| Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma L Pang, M Dunterman, W Xuan, A Gonzalez, Y Lin, WH Hsu, F Khan, ... Cell reports 42 (2), 2023 | 18 | 2023 |
| Oncogenic KRAS drives lipofibrogenesis to promote angiogenesis and colon cancer progression WH Hsu, KA LaBella, Y Lin, P Xu, R Lee, CE Hsieh, L Yang, A Zhou, ... Cancer discovery 13 (12), 2652-2673, 2023 | 8 | 2023 |
| Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma L Pang, M Dunterman, S Guo, F Khan, Y Liu, E Taefi, A Bahrami, C Geula, ... Nature Immunology 24 (10), 1654-1670, 2023 | 6 | 2023 |
| Telomerase reverse transcriptase preserves neuron survival and cognition in Alzhei‑mer’s disease models. Nat Aging 1: 1162–1174 HS Shim, JW Horner, CJ Wu, J Li, ZD Lan, S Jiang, X Xu, WH Hsu, T Zal, ... | 5 | 2021 |
| Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment. Cancer Discov. 2020; 10 (3): 371–81 P Chen, WH Hsu, A Chang, Z Tan, Z Lan, A Zhou, DJ Spring, FF Lang, ... CD-19-0400.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 4 | |
| LDHA-regulated tumor-macrophage symbiosis promotes glioblastoma progression F Khan, Y Lin, H Ali, L Pang, M Dunterman, WH Hsu, K Frenis, RG Rowe, ... Research Square, 2023 | 3 | 2023 |
| 592 ATR-mediated CD47 and PD-L1 upregulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer RCE Hsieh, S Krishnan, RC Wu, A Boda, A Liu, M Winkler, WH Hsu, S Lin, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 2 | 2021 |
